Evidence map›Paper›PMID 38903886›Full record

ArticlePeerJ2024

Potential therapeutic agents of

Thida Kaewkod, Puangphaka Kumseewai, Sureeporn Suriyaprom, Varachaya Intachaisri, Nitsanat Cheepchirasuk, Yingmanee Tragoolpua

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Thida KaewkodDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Puangphaka KumseewaiDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Sureeporn SuriyapromDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Varachaya IntachaisriDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Nitsanat CheepchirasukDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.
Yingmanee TragoolpuaDepartment of Biology, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand.

Funding

Natural Extracts and Innovative Products for Alternative Healthcare Research Group, Chiang Mai University Chiang Mai, ThailandResearch and Researcher for Industry (RRi) Master ScholarshipThailand Research Fund
6 · The paper itself

Abstract

Background: Pathogenic bacteria are the cause of most skin diseases, but issues such as resistance and environmental degradation drive the need to research alternative treatments. It is reported that silk cocoon extract possesses antioxidant properties. During silk processing, the degumming of silk cocoons creates a byproduct that contains natural active substances. These substances were found to have inhibitory effects on bacterial growth, DNA synthesis, the pathogenesis of hemolysis, and biofilm formation. Thus, silk cocoon extracts can be used in therapeutic applications for the prevention and treatment of skin pathogenic bacterial infections. Methods: The extract of silk cocoons with pupae (SCP) and silk cocoons without pupae (SCWP) were obtained by boiling with distilled water for 9 h and 12 h, and were compared to silkworm pupae (SP) extract that was boiled for 1 h. The active compounds in the extracts, including gallic acid and quercetin, were determined using high-performance liquid chromatography (HPLC). Furthermore, the total phenolic and flavonoid content in the extracts were investigated using the Folin-Ciocalteu method and the aluminum chloride colorimetric method, respectively. To assess antioxidant activity, the extracts were evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. Additionally, the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of silk extracts and phytochemical compounds were determined against skin pathogenic bacteria. This study assessed the effects of the extracts and phytochemical compounds on growth inhibition, biofilm formation, hemolysis protection, and DNA synthesis of bacteria. Results: The HPLC characterization of the silk extracts showed gallic acid levels to be the highest, especially in SCP (8.638-31.605 mg/g extract) and SP (64.530 mg/g extract); whereas quercetin compound was only detected in SCWP (0.021-0.031 mg/g extract). The total phenolics and flavonoids in silk extracts exhibited antioxidant and antimicrobial activity. Additionally, SCP at 9 h and 12 h revealed the highest anti-bacterial activity, with the lowest MIC and MBC of 50-100 mg/mL against skin pathogenic bacteria including

Indexed as

Anti-Bacterial AgentsAntioxidantsBombyxSilkAnimalsBiofilmsFree RadicalsHemolysisMicrobial Sensitivity TestsPupaAnti-Bacterial AgentsAntioxidantsFree RadicalsSilkAntibacteriaAntioxidantNon-sericinPathogenesisSilk extractSkin pathogenic bacteria

Identifiers

PMID38903886
PMCPMC11188935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.